Cardiovascular and neurological symptoms can appear together in a broader toxic presentation, especially when concentrated products, high doses, or additional substances are involved
Tirzepatide and cardiovascular disease A previous study has shown that tirzepatide can protect human cardiomyocytes by effectively ameliorating apoptosis, fibrosis, and hypertrophy when exposed to high glucose
At the studys conclusion, researchers found that participants who took GLP-1 medications containing semaglutide or tirzepatide had a 41% decrease in their overall risk of developing an obesity-related cancer
Du H, Meng X, Yao Y, Xu J (2022) The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimers disease
However, experts cautioned that the findings are still preliminary